Factor that doubles the risk of death from breast cancer identified

by Karolinska InstitutetMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at Karolinska Institutet in Sweden have discovered that the ri

Updated on: March 01,2024

Factor that doubles the risk of death from breast cancer identified

by Karolinska InstitutetMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at Karolinska Institutet in Sweden have discovered that the ri

Updated on:March 01,2024

Novel prognostic index to predict survival outcomes in gastric cancer patients

by Impact Journals LLCCancer-specific survival curve based on the inflammation-based prognostic index. Abbreviation: ICPI: inflammation based prognostic index. Credit:Oncotarget(2023). DOI

Updated on: January 30,2024

Novel prognostic index to predict survival outcomes in gastric cancer patients

by Impact Journals LLCCancer-specific survival curve based on the inflammation-based prognostic index. Abbreviation: ICPI: inflammation based prognostic index. Credit:Oncotarget(2023). DOI

Updated on:January 30,2024

Researchers uncover potential biomarkers of positive response to immunotherapy

by Denise Heady,University of California, Los AngelesResponse to ICI or MAPKi therapy is associated with increased T cell infiltration and enhanced interferon gamma (IFNγ) pathway activity in th

Updated on: January 30,2024

Researchers uncover potential biomarkers of positive response to immunotherapy

by Denise Heady,University of California, Los AngelesResponse to ICI or MAPKi therapy is associated with increased T cell infiltration and enhanced interferon gamma (IFNγ) pathway activity in th

Updated on:January 30,2024

Researchers map genetic signature of precursor to liver cancer

by Curtin UniversityProfessor Nina Tirnitz-Parker and Dr. Rodrigo Carlessi, from Curtin University. Credit: Curtin UniversityResearchers at Curtin University have identified the genetic signature

Updated on: February 24,2024

Researchers map genetic signature of precursor to liver cancer

by Curtin UniversityProfessor Nina Tirnitz-Parker and Dr. Rodrigo Carlessi, from Curtin University. Credit: Curtin UniversityResearchers at Curtin University have identified the genetic signature

Updated on:February 24,2024

New research shows unmet support needs can lead to worse clinical outcomes

by Sylvester Comprehensive Cancer CenterCredit: CC0 Public DomainCancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency depart

Updated on: January 12,2024

New research shows unmet support needs can lead to worse clinical outcomes

by Sylvester Comprehensive Cancer CenterCredit: CC0 Public DomainCancer patients with unmet supportive care needs are more likely to experience worse clinical outcomes, including more emergency depart

Updated on:January 12,2024

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

Updated on: January 13,2024

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

Updated on:January 13,2024

Multi-modal AI models for intermediate- to high-risk localized prostate cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainNRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910

Updated on: January 30,2024

Multi-modal AI models for intermediate- to high-risk localized prostate cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainNRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910

Updated on:January 30,2024

Researchers to test novel drug combination against toughest breast cancers

by University of California - San DiegoThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: National Ins

Updated on: June 15,2024

Researchers to test novel drug combination against toughest breast cancers

by University of California - San DiegoThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: National Ins

Updated on:June 15,2024

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Updated on: April 07,2024

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Updated on:April 07,2024

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of

Updated on: April 10,2024

Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainBased on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of

Updated on:April 10,2024

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Updated on: March 01,2024

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Updated on:March 01,2024

Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

by The Spanish National Cancer Research CentreGraphical abstract. Credit:EMBO Molecular Medicine(2023). DOI: 10.15252/emmm.202216715The drug denosumab is currently used to treat osteo

Updated on: January 30,2024

Researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment

by The Spanish National Cancer Research CentreGraphical abstract. Credit:EMBO Molecular Medicine(2023). DOI: 10.15252/emmm.202216715The drug denosumab is currently used to treat osteo

Updated on:January 30,2024